Guidant Corporation announced Monday it was discontinuing production of its Ancure Endograft System, less than a week after EndoVascular Technologies Inc., a Guidant subsidiary, pled guilty to 10 federal felony counts for not disclosing malfunctions of the device. On Thursday, EndoVascular agreed to pay fines of $92.4